TARS - Tarsus Pharmaceuticals Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-09-12)
Last
 49.36		 Change
 ⇓ -2.51   (-4.84%)		 Volume
  1,226,268
Open
 51.26		 High
 51.60		 Low
 48.36
8EMA (Daily)
 54.14		 40EMA (Daily)
 51.54		 50EMA (Daily)
 50.53		 STO (Daily)
 26.134		 MACD Hist (Daily)
 -2.529
8EMA (Weekly)
 51.444		 40EMA (Weekly)
 46.01		 50EMA (Weekly)
 44.78		 STO (Weekly)
 86.440		 MACD Hist (Weekly)
 2.367
Company Profile
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com